Free Anti-Ustekinumab

Free Anti-Ustekinumab
Detecting the development of Anti-drug antibodies (ADAs) against Ustekinumab in patients being treated with Ustekinumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Ustekinumab can detect the presence of anti-drug antibodies against Ustekinumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum
• Reaction Time 12 mins
  
• Detection Range 2.5~100 ng/mL
  
• Indication Quantitative determination of free antibodies to Ustekinumab in human whole blood/serum
  

Click